Review why we’re doing this work Display survey results

Slides:



Advertisements
Similar presentations
MaineCare’s New Medication Assisted Treatment (MAT)/Methadone Maintenance Therapy (MMT) Policy Kevin S. Flanigan, MD Medical Director Office of MaineCare.
Advertisements

Slide 1 Best Practices Working Group Chapter 244 Acts of 2012 Joint Policy Working Group Bureau of Health Care Safety and Quality Director Madeleine Biondolillo,
Characteristics of Patients Using Extreme Opioid Dosages in the Treatment of Chronic Low Back Pain In this sample of 204 participants, 70% were female,
Rx for Success Next Steps to Prevent Prescription Drug Abuse Rebecca Hebner, MPH Substance Abuse Prevention Systems Coordinator.
Origin and Process of Utah Guidelines Anna Fondario, MPH Utah Department of Health Violence and Injury Prevention Program.
Sharing and Learning. Our team members:  Physicians, MOAs, other staff One Chronic Pain Patient:  Male/female  Age  Occupation  Main complaint 
ASTHO Prescription Drug Misuse and Abuse Strategic Map:
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
A System to Manage Long Term Opioid Prescribing in the Primary Care Setting Joy Nassar, MD University Medicine Foundation November 16, 2015.
The AMA: Reducing Opioid Abuse in America Patrice A. Harris, MD, MA Board Chair American Medical Association September 2016.
HOPE Agenda Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN – ASSEMBLY DISTRICT 89.
Dental Patient Satisfaction Survey
OPIOID EPIDEMIC.
Wireless Access SSID: cwag2017
The Role of Dentists in Preventing Opioid Abuse
Illinois’ 1115 Behavioral Health Transformation Waiver
Cover slide.
Patient Centered Medical Home
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
Smartphone-Facilitated N-of-1 Trials for Improving Safety of Analgesic Regimens 1David Odineal, 2Rima Cabrera, 2Maria Marois, 2Sarah Benedetti, 2Peach.
New NC Medical Board Opioid Prescribing CME Requirements
6-Building Block Workshop
Mary McDonough RN Jeff Aalberg MD October 28, 2006 NESTFM
Nebraska Prescription Drug Overdose Prevention Program Efforts
Medication-Assisted Therapy at Coleman Profession Services
Medicaid National Meeting on Prescription Drug Abuse and Overdose
COLLECTIVE IMPACT APPROACH TO ADDRESSING
MWCC.MS.GOV  Services  Medical Fee Schedule
Place name sticker or stamp with card
Opioids Aware A resource for patients and HCPs to support prescribing of opioid medicines for pain Sue Mulvenna CDAO NHSE S SW March 2016.
Be the Change. Do Something.
An overdose Reduction PlaN
Falls Prevention Accreditation ROP Compliance
Opioids in chronic pain
STOP! Safe Treatment of Pain
A Recommendation from Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from ACOP and APS By Rhys Dela Cruz, Angela Hickey,
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
How Volunteers Can Impact Patient Safety
Buccaneers SAIL Safe Accountable In Control Lead by Example.
Opioid Prescribing & Monitoring
Complete a legally valid prescription.
Controlled substance compliance
Appropriate Opiate Prescribing: Managing Chronic Pain in a FQHC
What Works? Evidence-Based Practices for Treating Opioid Use Disorder
Prescription Drugs/Opiates Teen Norms Survey
Differentiating Drug-Seeking Behavior From Poorly Controlled Pain
Barbara Allison-Bryan, MD
2017 Opioid Prescriber Survey Preliminary Results
Opiate Roundtable March 29, 2018 Karen Burgess, MD
Opioids in Butte County
Prescription Drug Monitoring Program
An Interprofessional Perspective on the Safe and Appropriate Use of Opioid Analgesics.
Using Data to Combat the Opioid Overdose Crisis
Ten Pearls for Medication Assisted Treatment of Opiate Use Disorders
VCSQI Patient (Person) and Family Engagement (PFE) Survey
Cindy Murray NP Princess Margaret Cancer Centre
WisPQC Change Package November 27, :00-1:00 p.m. GoToWebinar®
Prescription Drug Monitoring Program
National Credentialing Forum 2019 San Diego, CA February
Pharmacy practice and the healthcare system Ola Ali Nassr
Essentials of Good Pain Care: A Team-Based Approach
Opioid prescribing workflow in the electronic medical record.
Academic Detailing (AD): A New Resource From AR-IMPACT
Rebecca Snead Executive Vice President & CEO NASPA
Celebrating Success and Making a Plan for Sustainability
Suzanne Carlberg-Racich, MSPH, PHD
Massachusetts Consultation Service for the Treatment of Addiction and Pain (MCSTAP) Offers real-time phone consultation to primary care practices on safe.
Strategic Initiatives to Address Opioid Overdose & Addiction
Chronic opioid registry health maintenance tool.
Presentation transcript:

May 24th – VCSQI Opioid Management Workgroup Today’s Objectives and Agenda Review why we’re doing this work Display survey results Recommended Actions Tell us your story! Today’s agenda is organized around our objectives for today, as seen here.

Opioids: Why This Work is Important

Opioids: Why This Work is Important

VCSQI Survey: Opioid Prescribing Practices-March 2018 Thursday, May 24, 2018

12 Total Responses Date Created: Wednesday, March 14, 2018 Complete Responses: 10

Q4: Do any clinicians in your practice prescribe opioids? Answered: 12 Skipped: 0

Q4: Do any clinicians in your practice prescribe opioids? Answered: 12 Skipped: 0

Q5: Does your practice have an opioid prescribing protocol used by your clinicians? Answered: 7 Skipped: 5

Q5: Does your practice have an opioid prescribing protocol used by your clinicians? Answered: 7 Skipped: 5

Q6: Do your prescribers use the your state's Prescription Drug Monitoring  Program (PDMP) when prescribing opioids? Check all that apply. Answered: 7 Skipped: 5

Q6: Do your prescribers use the your state's Prescription Drug Monitoring  Program (PDMP) when prescribing opioids? Check all that apply. Answered: 7 Skipped: 5

Q7: Do your prescribers assess a patient's risk of addiction prior to prescribing an opioid? Answered: 7 Skipped: 5

Q7: Do your prescribers assess a patient's risk of addiction prior to prescribing an opioid? Answered: 7 Skipped: 5

Q8: Does your practice have prescribing restrictions for the number of opiate pills prescribed? Answered: 7 Skipped: 5

Q8: Does your practice have prescribing restrictions for the number of opiate pills prescribed? Answered: 7 Skipped: 5

Q9: How many days/weeks of opiate pain medication do your prescribers typically prescribe? Answered: 7 Skipped: 5

Q9: How many days/weeks of opiate pain medication do your prescribers typically prescribe? Answered: 7 Skipped: 5

Q10: On average, how soon does your team follow up with patients who are receiving opiates? Answered: 7 Skipped: 5

Q10: On average, how soon does your team follow up with patients who are receiving opiates? Answered: 7 Skipped: 5

Q11: Do your prescribers document in the medical record a signed "opioid treatment agreement" between the patient and prescriber? Answered: 7 Skipped: 5

Q11: Do your prescribers document in the medical record a signed "opioid treatment agreement" between the patient and prescriber? Answered: 7 Skipped: 5

Q12: Do you have a patient/family education process to jointly determine how the patient can best manage pain and inform the patient of risks associated with opioids? Answered: 7 Skipped: 5

Q12: Do you have a patient/family education process to jointly determine how the patient can best manage pain and inform the patient of risks associated with opioids? Answered: 7 Skipped: 5

Q13: Does your patient/family education material include information about how to safely dispose of unused opioids? Answered: 7 Skipped: 5

Q13: Does your patient/family education material include information about how to safely dispose of unused opioids? Answered: 7 Skipped: 5

Q14: Where do your clinicians primarily see patients Q14: Where do your clinicians primarily see patients? (check all that apply) Answered: 7 Skipped: 5

Q14: Where do your clinicians primarily see patients Q14: Where do your clinicians primarily see patients? (check all that apply) Answered: 7 Skipped: 5

Q15: Do you currently measure/track opioid prescribing practices with your patients? (Check all that apply). Answered: 7 Skipped: 5

Q15: Do you currently measure/track opioid prescribing practices with your patients? (Check all that apply). Answered: 7 Skipped: 5

Q17: Are there any questions we did not ask that you would like to address, or that you think we SHOULD ask in future surveys on this topic? Open comment box Answered: 6 Skipped: 6

Q17: Are there any questions we did not ask that you would like to address, or that you think we SHOULD ask in future surveys on this topic? Open comment box Answered: 6 Skipped: 6

Survey Take-Away’s Most practices that prescribe opioids do NOT have a protocol The state’s PDMP is being used to check for other scripts Patient’s risk is being assessed prior to prescribing Prescribing limits exist, but most at 14 days, with follow up in 2 weeks Signed treatment agreement not being used, but discussion about risks is usually done Discussion about safe disposal not usually done Minimal measurement of opioid prescribing practices Should ask about naloxone prescribing

Recommended actions Review your state’s laws – there have been many new ones passed that require checking PDMP and have dosage and duration limits Establish a prescribing protocol that meets the law’s expectations* Consider non-opioid treatment regimens Document assessment of patient’s risk Consider a signed treatment agreement with chronic pain patients and those at high risk for addiction Consider monitoring the practice’s prescribing patterns to confirm compliance with law and best practices *https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm

Opportunities for Positive Change Treatment and reimbursement Medication-assisted treatment (MAT) Evidence-based non-opioid treatment options Tools to prevent overprescribing Prescribing limits Prescription Drug Monitoring Programs (PDMPs) Screening, education, and communication Provider and patient education

In the Words of a Patient… “I'm a good person. I'm a contributing member of society. I'm educated. I have a good job, make good money, have wonderful relationships with my loved ones. I'm so completely average. The only thing that sets me apart from that other young business professional that seems to have it all is that I'm addicted to opiates.” Source: http://apps.frontline.org/heroin-stories/story/42422-65836.html

Tell Us Your Story to Improve Prescribing Practices Demographic information Strategies used Type of initiative (i.e., decreasing opioid usage, increasing treatment access, etc.) Data collection methods Initiative success Person and Family Engagement (PFE) methods